SCHEMBL7862883

SCHEMBL7862883

CCCCCCNC(=O)c1cccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCOC)nc2)c1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CA2 P00918 1/20 0.40
SMPD1 P17405 1/20 0.40
MGLL Q99685 4/20 0.40
BCL2L1 Q07817 1/20 0.40
MCL1 Q07820 1/20 0.40
NAAA Q02083 1/20 0.40
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
CNR2 P34972 1/20 0.39
FBP1 P09467 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862723 0.97 SMN1; SMN2 (0.44) KMT2ASMN1; SMN2BCL2L1MCL1GAA
SCHEMBL7862689 0.93 RAB9A (0.43) KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL7869173 0.93 RAB9A (0.44) KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL7869413 0.92 SMPD1 (0.45) KMT2ASMN1; SMN2CA2SMPD1NAAA
SCHEMBL7871660 0.91 SMN1; SMN2 (0.42) KMT2ASMN1; SMN2BCL2L1MCL1MAPT
SCHEMBL7862801 0.91 CA2 (0.48) CA2MGLLNAAA
SCHEMBL9018042 0.90 SMN1; SMN2 (0.43) KMT2ASMN1; SMN2CA2SMPD1BCL2L1
SCHEMBL7862681 0.90 HSD17B10 (0.43) KMT2ASMN1; SMN2SMPD1MAPTRAB9A
SCHEMBL7871636 0.89 RAB9A (0.46) SMN1; SMN2RAB9A
SCHEMBL7867848 0.89 SMN1; SMN2 (0.45) KMT2ASMN1; SMN2SMPD1BCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed